Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United States
LM Hess, ZL Cui, XI Li, C Molife… - Current Medical Research …, 2021 - Taylor & Francis
Objectives Therapeutic advances for the treatment of patients with advanced/metastatic non-
small cell lung cancer (NSCLC) have led to additional options for care. This observational …
small cell lung cancer (NSCLC) have led to additional options for care. This observational …
Real‐world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with …
A Slowley, K Phiri, JK Multani, V Casey… - Thoracic …, 2023 - Wiley Online Library
Background Real‐world evidence is increasingly used to guide treatment and regulatory
decisions for non‐small cell lung cancer (NSCLC). Real‐world treatment patterns and …
decisions for non‐small cell lung cancer (NSCLC). Real‐world treatment patterns and …
A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non–Small Cell Lung Cancer
Background: Treatment strategies for metastatic non–small cell lung cancer (NSCLC) are
evolving rapidly and can be highly variable. Real-world evidence of treatment patterns and …
evolving rapidly and can be highly variable. Real-world evidence of treatment patterns and …
Population-based Treatment Patterns and Outcomes for Stage III Non–Small Cell Lung Cancer Patients: A Real-world Evidence Study
D Yusuf, RN Walton, M Hurry, C Farrer… - American journal of …, 2020 - journals.lww.com
Background: Most patients with stage III non–small cell lung cancer (NSCLC) develop
metastases and succumb to their cancer. Approaches to the treatment of stage III disease …
metastases and succumb to their cancer. Approaches to the treatment of stage III disease …
Treatment patterns for advanced non–small-cell lung cancer after platinum-containing therapy in US community oncology clinical practice
C McKay, T Burke, X Cao, AP Abernethy… - Clinical Lung Cancer, 2016 - Elsevier
Background Knowledge of the real-world treatment patterns for non–small-cell lung cancer
(NSCLC) can identify quality-of-care gaps and guide resource allocation needs. Our …
(NSCLC) can identify quality-of-care gaps and guide resource allocation needs. Our …
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a …
E Nadler, B Arondekar, KM Aguilar, J Zhou… - Journal of Cancer …, 2021 - Springer
Purpose Treatments for advanced non-small cell lung cancer (NSCLC) have evolved to
include targeted and immuno-oncology therapies, which have demonstrated clinical benefits …
include targeted and immuno-oncology therapies, which have demonstrated clinical benefits …
Treatment patterns and outcomes in patients with non-squamous advanced non-small cell lung cancer receiving second-line treatment in a community-based …
IW Pan, R Mallick, R Dhanda, E Nadler - Lung Cancer, 2013 - Elsevier
Objectives This retrospective study used the US Oncology iKnowMed™ database, billing
claims, and chart reviews to report treatment patterns and outcomes in late-stage non-small …
claims, and chart reviews to report treatment patterns and outcomes in late-stage non-small …
Real-world characteristics and outcomes of patients with advanced non-small cell lung cancer (aNSCLC) receiving immune checkpoint inhibitor.
9110 Background: Immune Checkpoint Inhibitors (ICIs) were first approved for the treatment
of aNSCLC in 2014, and since this time have seen rapid adoption in the marketplace. We …
of aNSCLC in 2014, and since this time have seen rapid adoption in the marketplace. We …
Milestone analyses of immune checkpoint inhibitors, targeted therapy, and conventional therapy in metastatic non–small cell lung cancer trials: A meta-analysis
GM Blumenthal, L Zhang, H Zhang… - JAMA …, 2017 - jamanetwork.com
Importance Novel intermediate end points may be useful to detect signals of early activity
and prioritize new therapies to treat patients with advanced malignant neoplasms, including …
and prioritize new therapies to treat patients with advanced malignant neoplasms, including …
Update of incidence, prevalence, survival, and initial treatment in patients with non–small cell lung cancer in the US
Importance Updated estimates of non–small cell lung cancer (NSCLC) in the US are
needed. Objective To calculate the most recent epidemiologic estimates of NSCLC in the …
needed. Objective To calculate the most recent epidemiologic estimates of NSCLC in the …